Viewing StudyNCT00003160



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003160
Status: UNKNOWN
Last Update Posted: 2011-04-20
First Post: 1999-11-01

Brief Title: Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
Sponsor: Theradex
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Primary Peritoneal Cavity Cancer
Fallopian Tube Cancer
Ovarian Cancer
Keywords:
Name View
primary peritoneal cavity cancer View
stage III ovarian epithelial cancer View
stage IV ovarian epithelial cancer View
recurrent ovarian epithelial cancer View
fallopian tube cancer View